POWER: PrehabilitatiOn Workshop and Mentored Exercise Programme in Patients Having Elective Aortic Aneurysm Repair (POWER)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04169217 |
Recruitment Status : Unknown
Verified February 2021 by Guy's and St Thomas' NHS Foundation Trust.
Recruitment status was: Recruiting
First Posted : November 19, 2019
Last Update Posted : February 10, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Protocol Short Title:
POWER Study - PrehabilitatiOn Workshop and mentored Exercise programme in patients having elective aortic aneurysm Repair
Population:
Patients scheduled for elective repair of aortic aneurysm at St. Thomas' Hospital
Screening and recruitment:
Eligible participants will be identified by the vascular team; during the weekly multi-disciplinary team meeting, or via the clinical nurse specialist from tertiary referrals.
Participant information leaflets will then be sent out to eligible patients 2 weeks before the outpatient appointment.
Recruitment will be carried out during surgical outpatient appointments. Written informed consent will be obtained and participants will be randomised into three groups.
This pilot study will help us to:
- To assess feasibility of screening, recruitment and retention
- To assess adherence to intervention and blinding.
- To generate outcome data that may be used to power definitive clinical trials
Primary objective To determine the feasibility of delivery of a randomised control trial.
Secondary objective (s) To determine baseline outcome data that may be used to power a randomised control trial.
Number of Subjects/Patients A convenience sample of 15 patients per group is planned, with a total of 45 patients recruited. At GSTT 200-250 aortic aneurysm operations are performed annually. We aim to recruit 40% of those eligible and screened. This would equate to 4-6 recruited per month.
Trial Design Single-blinded, randomised, controlled pilot study.
Patients will be allocated into the following groups:
Control group:
- Current standard practice, no prehabilitation workshop.
Non-mentored group:
- Prehabilitation workshop with no further patient contact.
- Participants to be given a prehab 'pack' which includes advice and a diary card.
Mentored group:
- Prehabilitation workshop with addition of regular 'mentoring' for up to 8 weeks after the workshop.
- Participants to be given a prehab 'pack' which includes advice and a diary card.
Primary Endpoints:
- Screening and recruitment
- Retention, blinding and follow up procedures.
- Adherence
Secondary Endpoints:
To determine baseline outcome data that may be used to power a randomised control trial by examining the following:
- Composite of post-operative cardiac, respiratory and renal complications at 30 days
- Mortality at 30 days following surgery.
- Length of postoperative hospital stay
- Quality of life (EQ-5DL)- post surgery.
- Tests of activity and function
Main Inclusion Criteria
Inclusion:
Elective all aortic aneurysm repair Willingness to return after 8 weeks for re-assessment of secondary measures Participants must have an e mail address.
Exclusions:
Urgent or emergency repair Contraindications to exercise (doesn't apply for short term illness) Severe musculoskeletal disorders preventing exercise
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cardiac Surgery | Behavioral: Prehabilitation | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 45 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Supportive Care |
Official Title: | Mentored Prehabilitation for Patients Having Aortic Aneurysm Surgery: a Pilot Randomised Control Trial |
Actual Study Start Date : | November 15, 2019 |
Estimated Primary Completion Date : | May 1, 2022 |
Estimated Study Completion Date : | June 1, 2022 |

Arm | Intervention/treatment |
---|---|
No Intervention: Control arm
This arm will not be in the prehabilitation group- as is current standard practice
|
|
Active Comparator: Group 2
This arm will be subject to a one off prehabilitation workshop and provided with a prehab booklet
|
Behavioral: Prehabilitation
A combination of on off workshop and mentored prehabilitation |
Experimental: Group 3- Mentored group
This arm will be subject to a one off workshop and provided with a prehab booklet- and additional mentoring by means of 1. an educational app, 2. push notifications,3. weekly communication with physiotherapy team member.
|
Behavioral: Prehabilitation
A combination of on off workshop and mentored prehabilitation |
- Feasibility of screening and recruitment: recruitment ratio [ Time Frame: 18 months ]Screening: recruitment ratio of 3:1
- Subject retention and adherence to 8-week follow up and blinding [ Time Frame: 8 weeks ]Subject wearing activity tracker for greater than 80% of the time. 80% or more attendance to 8-week follow up and 80% or more maintenance of blinding
- Adherence to trial protocol by comparing weekly physical activity between the three trial groups. [ Time Frame: 18 months ]Increase in activity in intervention groups of 30% or more compared to the control group as measured by the actiwatch
- Composite of post-operative cardiac complications at 30 days [ Time Frame: 30 days post surgery. ]MI, new onset arrhythmia, prolonged inotropic support ( > 12 hours post op)
- Composite of post-operative respiratory complications at 30 days [ Time Frame: 30 days post surgery ]Prolonged intubation > 12 hours, patient needing re- intubation, post-operative pneumonia
- Composite of post-operative renal complications at 30 days [ Time Frame: 30 days post surgery ]renal insufficiency needing haemofiltration, >20% increase in creatinine from baseline.
- Mortality at 30 days [ Time Frame: 30 days post surgery ]Mortality status of those in each group at 30 days
- Length of hospital stay [ Time Frame: 18 months ]How long each participant in each group stayed in hospital post surgical intervention
- Quality of life (QoL) EQ-5D [ Time Frame: 18 months ]Participants QoL through the study - baseline, pre-operative and 6 weeks post-operative. This may be unto 18 months.
- Tests of activity and function [ Time Frame: 8 weeks ]Duke Activity Status Index (DASI) score at baseline and at 8 weeks
- Tests of activity and function [ Time Frame: 8 weeks ]'Timed up and Go'- at baseline and 8 weeks
- Tests of activity and function [ Time Frame: 8 weeks ]Gait speed- at baseline and 8 weeks
- Tests of activity and function [ Time Frame: 8 weeks ]Leg Strength measured by hand held dynamometer- at baseline and 8 weeks

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
-
• Attending GSTT for aortic aneurysm surgery
- Ability to walk (determined by ability to perform gait speed independently)
- Willingness to wear the activity tracker for 8 weeks.
- Willingness to return at 8 weeks for re-assessment of secondary outcome measures
Exclusion Criteria:
-
Urgent or emergency aneurysm repair
- Patients who undergo emergency admission during the 8-week time frame, will be removed from the ongoing trial, but their data will be used up to that point.
- Contraindications to exercise (doesn't apply for short term illness ( appendix 4).
- Severe musculoskeletal disorders preventing exercise

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04169217
Contact: Heena Bidd | 07500 062989 | heena.bidd@gstt.nhs.uk | |
Contact: Gill Arbane | Gill.arbane@gstt.nhs.uk |
United Kingdom | |
Guy's and St Thomas' NHS Foundation Trust | Recruiting |
London, United Kingdom, SE1 7RT | |
Contact: Heena Bidd 0207 188 8070 heena.bid@gstt.nhs.uk | |
Contact: Gill Arbane 0207 188 8070 gill.arbane@gstt.nhs.uk |
Study Chair: | Heena Bidd | Guys & St Thomas' NHS Foundation Trust |
Responsible Party: | Guy's and St Thomas' NHS Foundation Trust |
ClinicalTrials.gov Identifier: | NCT04169217 |
Other Study ID Numbers: |
241950 |
First Posted: | November 19, 2019 Key Record Dates |
Last Update Posted: | February 10, 2021 |
Last Verified: | February 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Prehabilitation |
Aneurysm Aortic Aneurysm Vascular Diseases Cardiovascular Diseases Aortic Diseases |